$0.8197
0.0107[1.32%]
At close: Apr 26
$0.8197
0[0.00%]
After Hours: 7:01AM EDT
CytoSorbents
(NASDAQ:CTSO)Latest News for CytoSorbents Stock (NASDAQ:CTSO)
CytoSorbents Stock (NASDAQ: CTSO)
Categories: All
Friday, March 15, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Wednesday, January 17, 2024
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Jan 17, 2024, 8:05AM
- CytoSorbents Reports Outcomes From A Randomized Controlled Trial Using CytoSorb Blood Purification During Heart Transplant, Recently Published In The European Society Of Cardiology Journal, ESC Heart FailureBenzinga Newsdesk - Jan 17, 2024, 7:18AM
Friday, December 29, 2023
Thursday, December 28, 2023
- Gold Moves Lower; US Crude Stocks Decline Last WeekAvi Kapoor - Dec 28, 2023, 2:32PM
- Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Dec 28, 2023, 1:07PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Dec 28, 2023, 12:31PM
- Crude Oil Down 1%; US Wholesale Inventories Fall In NovemberAvi Kapoor - Dec 28, 2023, 12:07PM
- Cytosorbents shares are trading lower after the company announced an analysis by the independent DSMB on the STAR-T trial showed the study did not meet the primary effectiveness endpoint in the overall patient population.Benzinga Newsdesk - Dec 28, 2023, 10:25AM
- Dow Gains 50 Points; US Jobless Claims Rise To 218,000Avi Kapoor - Dec 28, 2023, 10:03AM
- Why Is Blood Purification Focused CytoSorbents Trading Lower Today?Vandana Singh - Dec 28, 2023, 9:01AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 28, 2023, 8:06AM
- CytoSorbents Says Identified Evidence Of Benefit Of Reduced Bleeding Complications In Patients Undergoing Isolated CABG Surgery, Although Primary Effectiveness Endpoint Of STAR-T Study Was Not Met In Overall PopulationBenzinga Newsdesk - Dec 28, 2023, 7:08AM
- CytoSorbents Provides Update On STAR-T Trial; Says Independent DSMB Concluded There Were No Issues With Device SafetyBenzinga Newsdesk - Dec 28, 2023, 7:05AM